Association between glucose metabolism, the circadian cycle and hypoxia: Evaluation of the NPAS2 and Rev-Erb-α protein serum levels in obstructive sleep apnea patients – a pilot study
Dental and Medical Problems · 2024
DOI: 10.17219/dmp/185718 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dental and Medical Problems, 2024. Verfasst von Filip Franciszek Karuga und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Sleep Medicine and Metabolic Disorders, Medical University of Lodz, Poland. Hauptthemen laut MEDLINE: Basic Helix-Loop-Helix Proteins, Sleep Apnea, Obstructive, Nerve Tissue Proteins, Nuclear Receptor Subfamily 1, Group D, Member 1. Die Arbeit wurde bisher 48-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
BACKGROUND: Obstructive sleep apnea (OSA) is one of the risk factors for diabetes mellitus type 2 (DM2). As OSA is associated with the disruption of the circadian rhythm, it affects circadian clock proteins, including neuronal PAS domain protein 2 (NPAS2) and nuclear receptor subfamily 1 group D member 1 (Rev-Erb-α). These proteins have been shown to be related to metabolic abnormalities, i.a., insulin resistance. OBJECTIVES: The present pilot study aimed to investigate the NPAS2 and Rev-Erb-α protein serum levels in the groups of patients with severe OSA and severe OSA+DM2 in comparison with healthy controls, taking into account correlations with polysomnography (PSG) parameters (e.g., oxygen saturation (SpO2) variables). MATERIAL AND METHODS: A total of 40 participants were included in the study. They were split into 3 groups as follows: the OSA group (n = 17; apnea-hypopnea index (AHI) >30, no DM2); the OSA+DM2 group (n = 7; AHI > 30 and DM2); and the control group (n = 16; AHI < 5, no DM2). All participants underwent a nocturnal PSG examination and had their blood collected the following morning. The serum levels of NPAS2 and Rev-Erb-α proteins were assessed using the enzyme-linked immunosorbent assay (ELISA). RESULTS: The mean NPAS2 protein level was significantly lower in the OSA group as compared to healthy individuals (p = 0.017). Additionally, the OSA group presented with lower NPAS2 protein levels as compared to the OSA+DM2 group, but only a tendency was observed (p = 0.094). No differences in the Rev-Erb-α protein concentration were noticed. Furthermore, a negative correlation between AHI during rapid eye movement (REM) sleep and the NPAS2 protein serum level was observed (r = -0.478; p = 0.002). CONCLUSIONS: Serum NPAS2 protein might be involved in metabolic dysregulation present among OSA patients, while the mechanism itself may be associated with REM sleep.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Sleep Medicine and Metabolic Disorders, Medical University of Lodz, Poland.
- Department of Gynecology, Oncological Gynecology and Treatment of Endometriosis, Polish Mother's Memorial Hospital - Research Institute, Lodz, Poland.
Zitieren
APA
Karuga, F. F., Jaromirska, J., Sochal, M., Białasiewicz, P., & Gabryelska, A. (2024). Association between glucose metabolism, the circadian cycle and hypoxia: Evaluation of the NPAS2 and Rev-Erb-α protein serum levels in obstructive sleep apnea patients – a pilot study. Dental and Medical Problems. https://doi.org/10.17219/dmp/185718
Vancouver
Karuga FF, Jaromirska J, Sochal M, Białasiewicz P, Gabryelska A. Association between glucose metabolism, the circadian cycle and hypoxia: Evaluation of the NPAS2 and Rev-Erb-α protein serum levels in obstructive sleep apnea patients – a pilot study. Dental and Medical Problems. 2024. doi:10.17219/dmp/185718
BibTeX
@article{Karuga2024,
author = {Karuga, Filip Franciszek and Jaromirska, Julia and Sochal, Marcin and Białasiewicz, Piotr and Gabryelska, Agata},
title = {Association between glucose metabolism, the circadian cycle and hypoxia: Evaluation of the NPAS2 and Rev-Erb-α protein serum levels in obstructive sleep apnea patients – a pilot study},
journal = {Dental and Medical Problems},
year = {2024},
doi = {10.17219/dmp/185718}
}
EUVIMED